Meeting
2011 Genitourinary Cancers Symposium
Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low- or intermediate-risk disease.
Authors
Nils Arvold
Harvard Radiation Oncology Program
Nils Arvold , Judd Moul , Brian Moran , Daniel Dosoretz , Lionel Banez , Michael Katin , Anthony D'Amico
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 29: 2011 (suppl 7; abstr 198)
Abstract #
198
Poster Bd #
A92
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
The risk of death from prostate cancer in men with Gleason Score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy.
First Author: David Dewei Yang
Poster
2018 ASCO Annual Meeting
Ten year treatment outcomes of radical prostatectomy vs external beam radiation therapy vs brachytherapy for 1,503 patients with intermediate risk prostate cancer.
First Author: Barry W. Goy
Poster
2018 Genitourinary Cancers Symposium
Ten year treatment outcomes of radical prostatectomy vs external beam radiation therapy vs. brachytherapy for 1,503 patients with intermediate risk prostate cancer.
First Author: Barry W. Goy
Poster
2018 Genitourinary Cancers Symposium
Heterogeneity in early oncologic outcomes among men with NCCN intermediate-risk prostate cancer treated with radical prostatectomy.
First Author: Kamyar Ghabili